| Attributes | Values |
|---|
| rdf:type
| |
| rdfs:seeAlso
| |
| Description
| - Objective of the study is to evaluate benefits of complete arterial myocardial revascularization and to compare it with %22conventional%22 CABG (e.g. IMA to LAD and vein grafts as needed) and to give relevant basis for decision making in clinical practice. (en)
- Podstatou projektu je objektivní zhodnocení přínosu tepenné revaskularizace myokardu v multicentrické prospektivní studii evropského formátu a tím dát podklady pro každodenní rozhodování v klinické praxi.
|
| Title
| - Complete arterial revascularization and conventional coronary artery bypass - CARRACAS study. (en)
- Úplná tepenná revaskularizace myokardu a konvenční aortokoronární bypass. Evropská randomizovaná multicentrická studie - CARRACAS.
|
| skos:notation
| |
| http://linked.open...avai/cep/aktivita
| |
| http://linked.open...kovaStatniPodpora
| |
| http://linked.open...ep/celkoveNaklady
| |
| http://linked.open...datumDodatniDoRIV
| |
| http://linked.open...i/cep/druhSouteze
| |
| http://linked.open...ep/duvernostUdaju
| |
| http://linked.open.../cep/fazeProjektu
| |
| http://linked.open...ai/cep/hlavniObor
| |
| http://linked.open...hodnoceniProjektu
| |
| http://linked.open...vai/cep/kategorie
| |
| http://linked.open.../cep/klicovaSlova
| - arterial revascularization;internal mammary artery;coronary artery bypass graftin (en)
|
| http://linked.open...ep/partnetrHlavni
| |
| http://linked.open...inujicichPrijemcu
| |
| http://linked.open...cep/pocetPrijemcu
| |
| http://linked.open...ocetSpoluPrijemcu
| |
| http://linked.open.../pocetVysledkuRIV
| |
| http://linked.open...enychVysledkuVRIV
| |
| http://linked.open...okUkonceniPodpory
| |
| http://linked.open...okZahajeniPodpory
| |
| http://linked.open...iciPoslednihoRoku
| |
| http://linked.open...atUdajeProjZameru
| |
| http://linked.open...usZobrazovaneFaze
| |
| http://linked.open...ai/cep/typPojektu
| |
| http://linked.open...jektu+dodavatelem
| - Zařazeno 763 pac.(38-65let),časná mortalita 0,79% bez statis.rozdílu. TAR neměla negativ.vliv na morbiditu,počet infarktů a komplikací.Průchodnost bypassů u LIMA je statis.lepší než VSM.Po 5 letech rozdíl v průchodnosti tepen.štěpů a VSM narůstá. (cs)
- Incl. 763 pts.(age 38-65),early mortality 0,79% without statist.difference.TAR had no adverse effect on morbidity,number of MI and other complications.Angiographic patency of LIMA grafts significantly better than SVG.After 5year difference is increasing. (en)
|
| http://linked.open...tniCyklusProjektu
| |
| http://linked.open.../cep/klicoveSlovo
| - internal mammary artery
- arterial revascularization
|
| is http://linked.open...vavai/cep/projekt
of | |
![[RDF Data]](/fct/images/sw-rdf-blue.png)
![[cxml]](/fct/images/cxml_doc.png)
![[csv]](/fct/images/csv_doc.png)
![[text]](/fct/images/ntriples_doc.png)
![[turtle]](/fct/images/n3turtle_doc.png)
![[ld+json]](/fct/images/jsonld_doc.png)
![[rdf+json]](/fct/images/json_doc.png)
![[rdf+xml]](/fct/images/xml_doc.png)
![[atom+xml]](/fct/images/atom_doc.png)
![[html]](/fct/images/html_doc.png)